Have a personal or library account? Click to login
Severe hemolytic disease of the fetus and newborn due to anti-E and anti-Jka
 Cover

Severe hemolytic disease of the fetus and newborn due to anti-E and anti-Jka

Open Access
|Feb 2021

References

  1. Moise KJ. Fetal anemia due to non-Rhesus-D red-cell alloimmunization. Semin Fetal Neonatal Med 2008;13: 207–14.
  2. Canti V, Del Rosso S, Tonello M, et al. Antiphosphatidylserine/prothrombin antibodies in antiphospholipid syndrome with intrauterine growth restriction and preeclampsia. J Rheumatol 2018;45:1263–72.
  3. Committee Opinion No. 644: The Apgar Score. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;126:e52–5.
  4. Kliegman RM, ed. Reference intervals for laboratory tests and procedures, Table 727-5. In: Kliegman RM, Ed. Nelson textbook of paediatrics. 20th ed. Philadelphia, PA: Elsevier, 2016:3465–72.
  5. Kramer LI. Advancement of dermal icterus in the jaundiced newborn. Am J Dis Child 1969;118:454–8.
  6. Ambalavanan N, Carlo WA. Digestive system disorders, jaundice and hyperbilirubinemia in the newborn. In: Kliegman RM, Ed. Nelson textbook of paediatrics. 20th ed. Philadelphia, PA: Elsevier, 2016:871–5.
  7. Ainley L, Jardim JR, Tan J, et al. Prevalence of maternal alloantibodies in a large teaching hospital and their impact on outcomes of fetuses/neonates. Transfus Med 2017;27:228–30.
  8. Jovanovic-Srzentic S, Djokic M, Tijanic N, et al. Antibodies detected in samples from 21,730 pregnant women. Immunohematology 2003;19:89–92.
  9. Joy SD, Rossi KQ, Krugh D, O’Shaughnessy RW. Management of pregnancies complicated by anti-E alloimmunisation. Obstet Gynecol 2005;105:24–8.
  10. Moran P, Robson SC, Reid MM. Anti-E in pregnancy. Br J Obstet Gynaecol 2000;107:1436–8.
  11. Makroo RN, Bhatia A, Gupta R, Phillip J. Prevalence of Rh, Duffy, Kell, Kidd & MNSs blood group antigens in the Indian blood donor population. Indian J Med Res 2013;137:521–6.
  12. Thakral B, Malhotra S, Saluja K, Kumar P, Marwaha N. Hemolytic disease of newborn due to anti-Jkb in a woman with high risk pregnancy. Transfus Apher Sci 2010;43:41–3.
  13. Tormey CA, Stack G. Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy-related antibodies. Blood 2009;114:4279–82.
  14. Ramsey G, Larson P. Loss of red cell antibodies over time. Transfusion 1988;28:102–65.
  15. Baek EJ, Park SC, Kwon YH, Kim CR. Hemolytic disease of newborn due to anti-Jka and the duration of antibody persistence. J Pediatr Child Health 2013;49:E101–2.
  16. Leonard A, Hittsonboal L, Pary P, et al. Identification of red blood cell antibodies in maternal breast milk implicated in prolonged hemolytic disease of the fetus and newborn. Transfusion 2019;59:1183–9.
  17. White J, Qureshi H, Massey E, et al. Guideline for blood grouping and red cell antibody testing in pregnancy. Transfus Med 2016;26:246–63.
DOI: https://doi.org/10.21307/immunohematology-2020-043 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 60 - 63
Published on: Feb 17, 2021
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 S. Mandal, S. Malhotra, G. Negi, A. Tiwari, S. Mitra, S. Basu, P. Singh, published by American National Red Cross
This work is licensed under the Creative Commons Attribution 4.0 License.